Pilot Evaluation of CVT-E002 in Pediatric Upper Respiratory Tract Infection.

PHASE2CompletedINTERVENTIONAL
Enrollment

75

Participants

Timeline

Start Date

November 30, 2005

Study Completion Date

April 30, 2006

Conditions
Upper Respiratory Infection
Interventions
DRUG

CVT-E002 ginseng extract

Trial Locations (2)

T6G 2R7

Stollery Children's Hospital, Edmonton

Unknown

Misericordia Child Health Clinic, Edmonton

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

University of Alberta

OTHER

collaborator

Capital Health, Canada

OTHER

lead

CV Technologies

INDUSTRY

NCT00255307 - Pilot Evaluation of CVT-E002 in Pediatric Upper Respiratory Tract Infection. | Biotech Hunter | Biotech Hunter